News Astellas suspended from UK pharma trade body ABPI takes action after finding firm misled investigation into its conduct.
Cancer Celgene forms R&D consortium with four US cancer centres New initiative attempts to find next generation of cancer therapies.
Views & Analysis Cancer central to ‘Question Time’-style debate Topics, ranging from the seven-days- a-week NHS to Brexit, were on the oncology panel's agenda.
News UK trailing Europe on access to cancer drugs - report UK has some of the lowest uptake of new cancer drugs.
News Novartis cancer drugs among raft of NICE recommendations NICE recommends funding for lung cancer and skin cancer treatments.
News Inaugural UK melanoma patient conference bridges doctor-pati... A total of 250 delegates including experts in the field and patients attended the event.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
